References
- Bowden DH. Macrophages, dust, and pulmonary diseases. Exp Lung Res. 1987; 12: 89–107
- Warheit DB, Carakostas MC, Hartsky MA, et al. Development of a short-term inhalation bio-assay to assess pulmonary toxicity of inhaled particles: comparison of pulmonary responses to carbonyl iron and silica. Toxicol Appl Pharmacol. 1991; 107: 350–368
- Driscoll KE, Lindenschmidt RC, Maurer JK, et al. Pulmonary response to inhaled silica or titanium dioxide. Toxicol Appl Pharmacol. 1991; 111: 201–210
- Dethloff LA, Gilmore LB, Gladen BC, et al. Effects of silica on the composition of the pulmonary extracellular lining. Toxicol Appl Pharmacol. 1986; 84: 66–83
- Driscoll KE, Maurer JK, Lindenschmidt RC, et al. Respiratory tract responses to dust: relationships between dust burden, lung injury, alveolar macrophage fibronectin release, and the development of pulmonary fibrosis. Toxicol Appl Pharmacol. 1990; 106: 88–101
- Antonini JM, McCloud CM, Reasor MJ. Acute silica toxicity: attenuation by amiodarone-induced pulmonary phospholipidosis. Environ Health Perspect. 1994; 102: 372–378
- Adams PC, Holt DW, Storey G CA, et al. Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy. Circulation 1985; 72: 1064–1075
- Marchlinski FE, Gansler TS, Waxman HL, et al. Amiodarone pulmonary toxicity. Ann Intern Med. 1982; 97: 839–845
- Mazue G, Vic P, Gouy D, et al. Recovery from amiodarone-induced lipidosis in laboratory animals: a toxicological study. Fundam Appl Toxicol. 1984; 4: 992–999
- Reasor MJ, Ogle CL, Kacew S. Amiodarone-induced pulmonary toxicity in rats: biochemical and pharmacological characteristics. Toxicol Appl Pharmacol. 1989; 97: 124–133
- Heath MF, Costa-Jussa FR, Jacobs JM, et al. The induction of pulmonary phospholipidosis and the inhibition of lysosomal phospholipases by amiodarone. Br J Exp Pathol. 1985; 66: 391–397
- Hostetler KY, Giordano JR, Jellison EJ. In vitro inhibition of lysosomal phospholipase A1 of rat lung by amiodarone and desethylamiodarone. Biochim Biophys Acta. 1988; 959: 316–321
- Martin WJ, Kachel DL, Vilen T, et al. Mechanism of phospholipidosis in amiodarone pulmonary toxicity. J Pharmacol Exp Ther. 1989; 251: 272–278
- Kodavanti UP, Mehendale HM. Amiodarone-and desethylamiodarone-induced pulmonary phospholipidosis, inhibition of phospholipases in vivo, and alteration of [14C]amiodarone uptake by perfused lung. Am J Respir Cell Mol Biol. 1991; 4: 369–378
- Hostetler KY, Reasor MJ, Walker ER, et al. Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats. Biochim. Biophys Acta. 1986; 875: 400–405
- Reasor MJ, Ogle CL, Walker ER, et al. Amiodarone-induced phospholipidosis in rat alveolar macrophages. Am Rev Respir Dis. 1988; 137: 510–518
- Reasor MJ. Drug-induced lipidosis and the alveolar macrophage. Toxicology 1981; 20: 1–33
- Witschi HP, Tryka AF, Lindenschmidt RC. The many faces of an increase in lung collagen. Fundam Appl Toxicol. 1985; 5: 240–250
- Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957; 226: 497–509
- Ames BN, Dubin BT. The role of polyamines in the neutralization of deoxyribonucleic acid. J Biol Chem. 1960; 235: 769–775
- Kannan R, Miller S, Singh BN. Tissue uptake and metabolism of amiodarone after chronic administration in rabbits. Drug Metab Dispos. 1985; 13: 646–650
- Lockard V, Kennedy R. Alterations in rabbit alveolar macrophages as a result of traumatic shock. Lab Invest. 1976; 35: 501–506
- Lapp NL, Castranova V. How silicosis and coal workers' pneumoconiosis develop: a cellular assessment. Occup Med: State Art Rev. 1993; 8: 35–56
- Dethloff LA, Gilmore LB, Brody AR, et al. Induction of intra- and extra-cellular phospholipids in the lungs of rats exposed to silica. Biochem J. 1986; 233: 111–118
- Miller BE, Hook G ER. Stimulation of surfactant phospholipid biosynthesis in the lungs of rats treated with silica. Biochem J. 1988; 253: 659–665
- Piguet PF, Vesin C, Grau GE, et al. Interleukin 1 receptor antagonist (IL-lra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine. 1993; 5: 57–61
- Wang Q, Giri SN, Hyde DM, et al. Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem Pharmacol. 1991; 42: 1115–1122
- Wang Q, Hollinger MA, Giri SN. Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment. J Pharmacol Exp Ther. 1992; 262: 127–132
- Li Q, Xu Y, Zhow Z, et al. The therapeutic effect of tetrandrine on silicosis. Chin J Tuber Respir Dis. 1981; 4: 321–325
- Huang T, Liu Y, Zhao S, et al. Changes of acid-soluble collagen from lungs of silicotic rats and tetrandrine-treated silicotic rats. Acta Biochem Biophys Sintea. 1981; 13: 61–68
- Idel H. Silicosis and mixed dust pneumoconiosis. INSERM. 1987; 155: 471–479
- Yu X, Zou C, Lim M. Observation of the effect of tetrandrine on experimental silicosis of rats. Ecotoxicol Environ Safety 1983; 7: 306–311
- Reist RH, Dey RD, Durham JP, et al. Inhibition of proliferative activity of pulmonary fibroblasts by tetrandine. Toxicol Appl Pharmacol. 1993; 122: 70–76